Cargando…

Cervical cancer apparent diffusion coefficient values during external beam radiotherapy

BACKGROUND AND PURPOSE: Apparent diffusion coefficient (ADC) reflects micro-enviromental changes and therefore might be useful in predicting recurrence prior to brachytherapy. The purpose of this study is to evaluate change in ADC of the primary tumour and pathologic lymph nodes during treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Peter, Mandija, Stefano, Werensteijn-Honingh, Anita M., van den Berg, Cornelis A.T., de Leeuw, Astrid A.C., Jürgenliemk-Schulz, Ina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807732/
https://www.ncbi.nlm.nih.gov/pubmed/33458429
http://dx.doi.org/10.1016/j.phro.2019.03.001
_version_ 1783636805093949440
author de Boer, Peter
Mandija, Stefano
Werensteijn-Honingh, Anita M.
van den Berg, Cornelis A.T.
de Leeuw, Astrid A.C.
Jürgenliemk-Schulz, Ina M.
author_facet de Boer, Peter
Mandija, Stefano
Werensteijn-Honingh, Anita M.
van den Berg, Cornelis A.T.
de Leeuw, Astrid A.C.
Jürgenliemk-Schulz, Ina M.
author_sort de Boer, Peter
collection PubMed
description BACKGROUND AND PURPOSE: Apparent diffusion coefficient (ADC) reflects micro-enviromental changes and therefore might be useful in predicting recurrence prior to brachytherapy. The purpose of this study is to evaluate change in ADC of the primary tumour and pathologic lymph nodes during treatment and to correlate this with clinical outcome. MATERIAL AND METHODS: Twenty patients were included who received chemoradiation for locally advanced cervical cancer between July 2016 and November 2017. All patients underwent magnetic resonance imaging (MRI) prior to treatment, and three MRIs in weeks 1/2, 3 and 4 of treatment, including T2 and diffusion weighted imaging (b-values 0, 200, 800 s/mm(2)) for determining an ADC-map. Primary tumour was delineated on T2 and ADC-map and pathologic lymph nodes were delineated only on ADC-map. RESULTS: At time of analysis median follow-up was 15 (range 7–22) months. From MRI one to four, primary tumour on ADC-map showed a significant signal increase of 0.94 (range 0.74–1.46) × 10(−3) mm(2)/s to 1.13 (0.98–1.49) × 10(−3) mm(2)/s (p < 0.001). When tumour was delineated on T2, ADC-value signal increase (in tumour according to T2) was similar. All 46 delineated pathologic lymph nodes showed an ADC-value increase on average from 0.79 (range 0.33–1.12) × 10(−3) mm(2)/s to 1.14 (0.59–1.75) × 10(−3) mm(2)/s (p < 0.001). The mean tumour/suspected lymph node volumes decreased respectively 51/40%. Four patients developed relapse (one local and three nodal), without clear relation with ΔADC. However, the median volume decrease of the primary tumour was substantially lower in the failing patients compared to the group without relapse (19 vs. 57%). CONCLUSIONS: ADC values can be acquired using T2-based tumour delineations unless there are substantial shifts between ADC-mapping and T2 acquisition. It remains plausible that ΔADC is a predictor for response to EBRT. However, the correlation in this study was not statistically significant.
format Online
Article
Text
id pubmed-7807732
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78077322021-01-14 Cervical cancer apparent diffusion coefficient values during external beam radiotherapy de Boer, Peter Mandija, Stefano Werensteijn-Honingh, Anita M. van den Berg, Cornelis A.T. de Leeuw, Astrid A.C. Jürgenliemk-Schulz, Ina M. Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: Apparent diffusion coefficient (ADC) reflects micro-enviromental changes and therefore might be useful in predicting recurrence prior to brachytherapy. The purpose of this study is to evaluate change in ADC of the primary tumour and pathologic lymph nodes during treatment and to correlate this with clinical outcome. MATERIAL AND METHODS: Twenty patients were included who received chemoradiation for locally advanced cervical cancer between July 2016 and November 2017. All patients underwent magnetic resonance imaging (MRI) prior to treatment, and three MRIs in weeks 1/2, 3 and 4 of treatment, including T2 and diffusion weighted imaging (b-values 0, 200, 800 s/mm(2)) for determining an ADC-map. Primary tumour was delineated on T2 and ADC-map and pathologic lymph nodes were delineated only on ADC-map. RESULTS: At time of analysis median follow-up was 15 (range 7–22) months. From MRI one to four, primary tumour on ADC-map showed a significant signal increase of 0.94 (range 0.74–1.46) × 10(−3) mm(2)/s to 1.13 (0.98–1.49) × 10(−3) mm(2)/s (p < 0.001). When tumour was delineated on T2, ADC-value signal increase (in tumour according to T2) was similar. All 46 delineated pathologic lymph nodes showed an ADC-value increase on average from 0.79 (range 0.33–1.12) × 10(−3) mm(2)/s to 1.14 (0.59–1.75) × 10(−3) mm(2)/s (p < 0.001). The mean tumour/suspected lymph node volumes decreased respectively 51/40%. Four patients developed relapse (one local and three nodal), without clear relation with ΔADC. However, the median volume decrease of the primary tumour was substantially lower in the failing patients compared to the group without relapse (19 vs. 57%). CONCLUSIONS: ADC values can be acquired using T2-based tumour delineations unless there are substantial shifts between ADC-mapping and T2 acquisition. It remains plausible that ΔADC is a predictor for response to EBRT. However, the correlation in this study was not statistically significant. Elsevier 2019-03-14 /pmc/articles/PMC7807732/ /pubmed/33458429 http://dx.doi.org/10.1016/j.phro.2019.03.001 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
de Boer, Peter
Mandija, Stefano
Werensteijn-Honingh, Anita M.
van den Berg, Cornelis A.T.
de Leeuw, Astrid A.C.
Jürgenliemk-Schulz, Ina M.
Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title_full Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title_fullStr Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title_full_unstemmed Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title_short Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
title_sort cervical cancer apparent diffusion coefficient values during external beam radiotherapy
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807732/
https://www.ncbi.nlm.nih.gov/pubmed/33458429
http://dx.doi.org/10.1016/j.phro.2019.03.001
work_keys_str_mv AT deboerpeter cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy
AT mandijastefano cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy
AT werensteijnhoninghanitam cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy
AT vandenbergcornelisat cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy
AT deleeuwastridac cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy
AT jurgenliemkschulzinam cervicalcancerapparentdiffusioncoefficientvaluesduringexternalbeamradiotherapy